International Journal of Spectroscopy

International Journal of Spectroscopy / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 768917 | https://doi.org/10.1155/2014/768917

Afaf A. Abdelmonem, Gamal H. Ragab, Hisham Hashem, Eman A. Bahgat, "Simple Atomic Absorption Spectroscopic and Spectrophotometric Methods for Determination of Pioglitazone Hydrochloride and Carvedilol in Pharmaceutical Dosage Forms", International Journal of Spectroscopy, vol. 2014, Article ID 768917, 17 pages, 2014. https://doi.org/10.1155/2014/768917

Simple Atomic Absorption Spectroscopic and Spectrophotometric Methods for Determination of Pioglitazone Hydrochloride and Carvedilol in Pharmaceutical Dosage Forms

Academic Editor: Shigehiko Takegami
Received31 Jan 2014
Revised06 Apr 2014
Accepted14 Apr 2014
Published18 May 2014

Abstract

This study represents simple atomic absorption spectroscopic and spectrophotometric methods for determination of pioglitazone hydrochloride (PGZ-HCl) and carvedilol (CRV) based on formation of ion-pair associates between drugs and inorganic complex, bismuth(III) tetraiodide (Method A) and between drugs and organic acidic dyes, fast green and orange G (Method B). Method A is based on formation of ion-pair associate between drugs and bismuth(III) tetraiodide in acidic medium to form orange-red ion-pair associates, which can be quantitatively determined by two different procedures. The formed ion-pair associate is extracted by methylene chloride, dissolved in acetone, dried, and then decomposed by hydrochloric acid, and bismuth content is determined by direct atomic absorption spectrometric technique (Procedure 1) or extracted by methylene chloride, dissolved in acetone, and quantified spectrophotometrically at 490 nm (Procedure 2). Method B is based on formation of ion-pair associate between drugs and either fast green dye or orange G dye in acidic medium to form ion-pair associates. The formed ion-pair associate is extracted by methylene chloride and quantified spectrophotometrically at 630 nm (for fast green dye method) or 498 nm (for orange G dye method). Optimal experimental conditions have been studied. Both methods are applied for determination of the drugs in tablets without interference.

1. Introduction

PGZ-HCl, (±)-5-{p-[2-(5-ethyl-2-pyridyl) ethoxy] benzyl}-2,4-thiazolidine dione hydrochloride (Figure 1(a)), is a thiazolidine-dione oral antidiabetic similar to rosiglitazone. It is used in the management of type 2 diabetes mellitus. It is given orally as a monotherapy, particularly in patients who are overweight and for whom metformin is contraindicated or not tolerated [1].

Several spectrophotometric methods have been reported for estimation of PGZ-HCl including ion-pair complex formation with bromothymol blue, bromophenol blue and bromocresol purple [2], and chlorophenol red [3] as well as interaction with diazotized sulfanilic acid [4]. Derivative spectrophotometry [5] has been also applied. An atomic absorption spectrometric method for determination of PGZ-HCl has been reported which is based on reaction of the drug with calcium disodium edentate and sodium chloride to give pink and violet colored metal complexes, respectively [6]. These complexes are readily extracted with chloroform and determined by atomic absorption spectrometer at 288.2 and 227.7 nm, respectively [6]. Other methods include flow injection analysis [7] and voltametry [8]. Chromatographic methods [911] have been reported such as very rapid separation and quantitation of PGZ-HCl in presence of metformin-HCl on monolithic column [9] as well as a stability indicating densitometric RP-TLC method [10].

CRV, (2RS)-1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy) ethyl]amino}-propan-2-ol (Figure 1(b)), is a beta-adrenoceptor antagonist, an arteriolar vasodilator that is indicated for the treatment of hypertension, angina pectoris, and heart failure [1].

CRV and its pharmaceutical formulations have been assayed in BP [14] which describes nonaqueous titration by dissolving the drug in anhydrous acetic acid and then titration with 0.1 M perchloric acid, determining the end-point potentiometrically. Several spectrophotometric methods have been reported for estimation of CRV including ion-pair complex formation with bromocresol green and bromothymol blue as well as charge-transfer reaction of the drug with the sigma-acceptor iodine [15]. Also UV spectrophotometric determination of CRV in pharmaceutical formulations was applied [1618]. Other methods including determination of CRV by its quenching effect on the luminescence of terbium complex in dosage form [19], spectrofluorimetric determination via derivatization with 7-Chloro-4-niritrobenzofurazon [20], and nonaqueous titration [21] have been described. Chromatographic methods have been reported such as validated HPLC determination of the fixed dose combination (CRV and hydrochlorothiazide) in their tablets [22], HPLC with fluorescence detection [23], and RP-HPLC method for monitoring of the photochemical stability of CRV and its degradation products [24]. A Chiral HPLC-separation and determination of CRV from human urine was also noticed [25]. A stability-indicating HPLC-DAD determination of a mixture of carvedilol and hydrochlorothiazide [26] and also UPLC-MS/MS method for assay of carvedilol and its active metabolite in human plasma were introduced [27]. No atomic absorption spectrometric methods have been previously reported for CRV determination.

Bismuth(III)-iodide compounds have been used as reagents for determination of some nitrogenous drugs such as amineptine hydrochloride, piribedil, and trimebutine maleate [28]. It has been also used for spectrophotometric and atomic absorption spectroscopic determination of moxifloxacin hydrochloride [29] as well as levofloxacin, norfloxacin, and ciprofloxacin [30]. It has been also used for conductometric determination of lomefloxacine HCl, pantoprazole sodium, and sumatriptan succinate [31]. On mixing aqueous solutions of bismuth(III) tetraiodide complex and the cited drugs in an acidic medium, a reddish orange precipitate instantaneously appeared that is attributed to the ion pair formed in the reaction (Scheme 1). The formed precipitates are then extracted and quantified spectrophotometrically at 490 nm or filtered, dried, and then decomposed by hydrochloric acid, and the bismuth content is determined by AAS at 223.1 nm [31].

768917.sch.001

Fast green FCF (Figure 2(a)) is an acidic dye used for spectrophotometric determination of some anthelmintics [32], mebeverine [33], and ceftiofur [34]. It has been also used for kinetic spectrophotometric determination of trace ruthenium [35] and in catalytic analysis of ultratrace ruthenium with oscillopolarographic detection [36].

Orange G (Figure 2(b)) is also an acidic dye used for spectrophotometric determination of citalopram hydrobromide, donepezil hydrochloride, rabeprazole sodium [37] from tablet formulation, omeprazole [38], tramadol hydrochloride [39], drotaverine hydrochloride [40], and some antihistaminic and skeletal muscle relaxant drugs [41]. It has been also used for spectrophotometric determination of trace ruthenium [42] and cationic and anionic surfactants in the presence of nonionic surfactants [43].

In this paper, new and simple atomic absorption spectroscopic and spectrophotometric methods are proposed for determination of some nitrogenous drugs, based on the formation of ion pair associated with Bi(III)-iodide complex, fast green or orange G dyes. The proposed methods have been applied to the assay of these drugs in tablets.

2. Experiment

2.1. Apparatus

All of the spectrophotometric measurements were carried out using a Shimadzu UV-1800 with matched 1 cm quartz cells (Japan). A Lutron digital pH-meter was used for pH adjustment (103 Taipei, Taiwan). Shimadzu atomic absorption spectrophotometric model AA-640-13 was used.

2.2. Materials

All solutions were prepared with analytical-grade chemicals and water was always doubly distilled. The studied drugs were of pharmaceutical grade. Standard bismuth(III) solution,  M, was prepared by dissolving 0.4824 g of bismuth subnitrate (Evans, united kingdom) in 5 mL of conc. HNO3 and adding distilled water and standardized complexometrically [43]. 0.5 M potassium iodide was prepared by dissolving 8.33 g of KI (Universal fine chemicals PVT-LTD, India) in 100 mL of water. Solutions of lower concentration were obtained by accurate dilution of these solutions with water. Acetic acid, hydrochloric acid, and sulphuric acid solutions of different molarities were prepared as in recommended methods [44]. Fast green FCF (Sigma Chem. Company, Milwaukee, WI, USA) was used as 0.01% w/v in double distilled water. Orange G (Sigma Chem. Company, Milwaukee WI, USA) was used as 0.2% w/v and 0.4% w/v in double distilled water.

2.3. Pharmaceutical Preparations

The following available pharmaceutical preparations were obtained from the Egyptian market and analyzed:(i)Diabetin tablets containing 30 mg PGZ-HCl per tablet (product of Unipharma, El-Obour city, Egypt);(ii)Carvid tablets labeled to contain 25 mg CRV per tablet (product of Multi-Apex Pharma, Badr city, Egypt).

2.4. Preparation of Standard Drug Solutions

For Method A. PGZ-HCl (Unipharma, El-Obour city, Egypt) stock solution, 0.25 mgmL−1, was prepared by dissolving 12.5 mg of PGZ in 5 mL of 0.1 M HCI and diluting to 50 mL with water (for both Procedure 1 and Procedure 2).

CRV (Amoun Pharmaceutical Co, El-Obour city, Egypt) stock solution was prepared by dissolving 50 mg of the drug in methanol and diluting to 100 mL with methanol. A 12.5 mL aliquot of this solution was diluted to 25 mL with water to obtain drug with 0.25 mgmL−1 concentration (for Procedure 1). Another CRV stock solution was prepared by dissolving 50 mg of the drug in methanol and diluting to 50 mL with methanol. A 10 mL aliquot of this solution was diluted to 25 mL with water to obtain drug with 0.4 mg mL−1 concentration (for Procedure 2).

For Method B. PGZ-HCl (Unipharma, El-Obour city, Egypt) working solution 50 μg mL−1 and for molar ratio  M solution were prepared by dissolving in the least amount of 0.1 M HCl and then completing to volume with distilled water for fast green FCF method, while for orange G method, working solution 1000 μgmL−1 and, for molar ratio,  M solution were prepared by dissolving in the least amount of 0.5 M H2SO4 and then completing to volume with distilled water.

CRV (Amoun Pharmaceutical Co, El-Obour city, Egypt) working solution 50 μgmL−1 and for molar ratio  M solution were prepared by dissolving in the least amount of methanol and then completing to volume with distilled water for fast green FCF method, while for orange G method, working solution 500 μgmL−1 and for molar ratio,  M solution were prepared by dissolving in the least amount of methanol and then completing to volume with distilled water.

2.5. General Procedures
2.5.1. Construction of Calibration Curves

For Method A

Procedure 1. Specified amounts of  M bismuth subnitrate and 0.5 M KI solutions were placed in a 60 mL separating funnel. Different aliquots of PGZ-HCl ranging from 0.1 to 1 mL of standard working solution and different aliquots of CRV ranging from 0.2 to 1.6 mL of standard working solution were added and pH is adjusted to 2.4 by adding an appropriate amount of HNO3 (2% v/v). The solution was completed to 10 mL with water in case of PGZ-HCl, but no water was added in case of CRV, and then 5 mL of methylene chloride and 0.5 mL of acetone were added and shaken for 2 minutes. The organic layer was filtered through a Whatman no. 41 filter paper and dried in boiling water bath. The dried organic phase was dissolved in 0.5 mL Conc. HCl and the volume was completed to 5 mL with double distilled water. A blank omitting the drug was prepared under the same conditions. The bismuth absorbance was measured at the following conditions:(i)analysis wavelength 223 nm;(ii)lamp current 5 mA;(iii)slit width 3.8 Å;(iv)burner height 5 mm;(v)burner slot, flame 10 cm, air-C2H2;(vi)support gas flow 10 Lmin−1;(vii)fuel gas flow 2.6 Lmin−1;(viii)absorption sensitivity 0.6 ppm.

The concentration of the consumed bismuth was calculated from calibration graph of standard bismuth subnitrate solution.

Procedure 2. Specified amounts of  M bismuth subnitrate and 0.5 M KI solutions were placed in a 60 mL separating funnel. Different aliquots of PGZ-HCl ranging from 0.3 to 1.3 mL of standard working solution and different aliquots of CRV ranging from 0.2 to 0.9 mL of standard working solution were added and pH is adjusted to 2.4 by adding an appropriate amount of HNO3 (2% v/v). The solution was completed to 10 mL with water in case of PGZ-HCl, but no water was added in case of CRV; then, 5 mL of methylene chloride and 0.5 mL of acetone were added for both drugs and shaken for 2 minutes. The organic layer was filtered through a Whatman no. 41 filter paper and measured at 490 nm against a reagent blank prepared and treated similarly.

For Method B

Fast Green FCF Method. Aliquots of standard solutions ranging from 0.1 to 0.7 and 0.1 to 0.6 mL of PGZ-HCl and CRV, respectively, were transferred into a series of 60 mL separating funnels. To each separating funnel, 1 mL of fast green FCF dye (0.01% w/v) was added followed by specific volumes of acetic acid. PGZ-HCl produced intense color without using acetic acid. The formed ion pairs were extracted with  mL of methylene chloride. The solutions were vigorously shaken for one minute and the separated organic layer dried over anhydrous sodium sulphate and transferred into 10 mL volumetric flasks. The volumes were completed to 10 mL with methylene chloride. The absorbance of the colored solutions was measured at 631 nm against reagent blank treated similarly.

Orange G Method. Aliquots of standard solutions ranging from 0.1 to 0.7 and 0.2 to 0.9 mL of PGZ-HCl and CRV, respectively, were transferred into a series of 60 mL separating funnels. To PGZ-HCl and CRV, 0.5 mL of 0.4% w/v and 0.2% w/v orange G dye were added, respectively, followed by specific volumes of acetic acid. PGZ-HCl produced intense color without using acetic acid (Table 2). The formed ion pairs were extracted with  mL of methylene chloride. The solutions were vigorously shaken for one minute and the separated organic layer was dried over anhydrous sodium sulphate and transferred into 10 mL volumetric flasks. The volumes were completed to 10 mL with methylene chloride. The absorbance of the colored solutions was measured at 498 nm against reagent blank treated similarly.

2.5.2. Procedure for Dosage Forms

(1) Analysis of Diabetin Tablets (PGZ-HCl)

For Method A. An accurately weighed amount of the powdered tablets equivalent to 25 mg of the drug was transferred to a beaker and extracted with 5 mL of 0.1 M HCl for 10 min and diluted with water. The mixture was filtered through a filter paper and washed with water. The filtrate and washing were collected in a 50 mL volumetric flask and diluted to volume with water and then subjected to analysis by the recommended procedure.

For Method B

Fast Green FCF Method. Weigh and finely powder 10 tablets. Extract an accurately weighed portion of the powder equivalent to about 10 mg of the drug with 10 mL of 0.1 M HCl by occasional shaking for 15 minutes. Filter the mixture into 100 mL calibrated flask, then wash the residue several times with the same solvent and dilute to 100 mL with the same solvent. Take 5 mL of this stock and dilute to 10 mL with distilled water.

Orange G Method. Weigh and finely powder 10 tablets. Extract an accurately weighed portion of the powder equivalent to about 25 mg of the drug with 10 mL of 0.5 M H2SO4 by occasional shaking for 15 minutes. Filter the mixture into 25 mL calibrated flask, wash the residue several times with the same solvent, and dilute to 25 mL with the same solvent.

(2) Analysis of Carvid Tablets (CRV)

For Method A. An accurately weighed amount of the powdered tablets equivalent to 50 mg of the drug was transferred to a beaker, extracted with methanol, filtered through a filter paper, and washed with methanol. The filtrate and washing were collected in a 50 mL volumetric flask and diluting to volume with methanol. A 10 mL aliquot of this solution was diluted to 25 mL with water to obtain 0.4 mg mL−1 of CRV and then subjected to analysis by the recommended procedure.

For Method B

Fast Green FCF Method. Weigh and finely powder 10 tablets. Extract an accurately weighed portion of the powder equivalent to about 25 mg of the drug with 10 mL of methanol by occasional shaking for 15 minutes. Filter the mixture into 100 mL calibrated flask, wash the residue several times with the same solvent, and dilute to 100 mL with the same solvent. Take 10 mL of this stock and dilute to 50 mL with distilled water.

Orange G Method. Weigh and finely powder 10 tablets. Extract an accurately weighed portion of the powder equivalent to about 50 mg of the drug with 10 mL of methanol by occasional shaking for 15 minutes. Filter the mixture into 50 mL calibrated flask, wash the residue several times with the same solvent, and dilute to 50 mL with the same solvent. Take 5 mL of this stock and dilute to 10 mL with distilled water.

3. Results and Discussion

3.1. For Method A

Bismuth(III)-iodide compounds have been used as reagents for the determination of some nitrogenous drugs. The formation of the ion pair between the secondary or tertiary amine group of the drug and Bi(III)-iodide binary complex occurs via the protonated nitrogen atom of the drug. On mixing aqueous solutions of Bi(III)-iodide complex and the cited drugs in an acidic medium, a reddish orange precipitate appears that is attributed to the ion pairs formed in the reaction. The extraction of these ion pairs with different solvents was studied. Only low-polarity solvents, such as chloroform, methylene chloride, and ethylene chloride, selectively extract the ion pairs. Methylene chloride was chosen as the extraction solvent because of its higher efficiency and considerable lower extraction ability for the reagent blank. Addition of a small amount of acetone proved to be useful. Ion pair in methylene chloride was measured over the wavelength range 400–560 nm. The ion pair shows maximum absorbance at 490 nm (Figures 3 and 4), which can therefore be used as the wavelength for the analytical determination. The reagent blank at this wavelength has a low absorbance.

All measurements were performed against a reagent blank. Results are shown in Table 1. Different variables affecting the reaction were studied. It was not practical to aspirate the organic solvent of ion pair in the atomic absorption spectrometer because the high chlorine-carbon ratio would lead to the formation of a large quantity of HCl in the frame which would damage the instrument [41]. To avoid this damage, ion pair was extracted with organic solvent and dried and then the residue was dissolved in conc. HCl. Different solvents were tried to dissolve the residue such as conc. ammonium hydroxide and conc. HCl, and it was found that conc. HCl is the suitable solvent for dissolving the ion pair as it gives maximum solubility and best sensitivity.


ParametersPGZ-HClCRV
Procedure 1Procedure 2Procedure 1Procedure 2

(nm)223490223490
Beer's law limits ( g mL−1)5–5015–6510–8016–72
Vol. and conc. of bismuth subnitrate of  M0.3 mL0.3 mL0.4 mL0.4 mL
Vol. and conc. of potassium iodide of 0.5 M0.5 mL0.5 mL0.7 mL0.7 mL
Extracting solventMethylene
chloride
Methylene
chloride
Methylene
chloride
Methylene
chloride
Regression equation**
 Slope ( )2.76420.01433.73830.0136
 Intercept ( )102.520.017755.097−0.0932
 Correlation coefficient ( )0.99990.99990.99990.9999
 Molar ratio1 : 11 : 11 : 11 : 1
, where is the concentration of drug in gmL−1, is the absorbance,
is the intercept, and is the slope

Average of three experiments.

PGZ-HClCRV
Procedure 1Procedure 2Procedure 1Procedure 2
Conc.
Taken gmL−1
Conc. Found gmL−1Recovery (%)Conc.
Taken gmL−1
Conc. Found gmL−1Recovery (%)Conc.
Taken µgmL−1
Conc. Found gmL−1Recovery (%)Conc.
Taken µgmL−1
Conc. Found gmL−1Recovery (%)

54.8897.531515.20101.31109.8798.721616.04100.28
109.9499.412524.9999.942525.12100.482424.13100.55
1515.01100.043534.9299.764040.10100.254039.5098.75
2525.14100.544544.9299.816060.16100.274847.8199.60
3535.27100.765555.34100.617069.52100.325656.12100.21
4545.03100.076565.13100.198080.22100.287271.9399.90
5049.7499.47
Mean99.69100.2799.9899.88
±SD1.070.590.70.64
±RSD1.070.590.70.64
SE0.410.240.290.26
Variance1.150.350.490.41
Slope2.76420.01433.73830.0136
LOD
gmL−1
1.822.663.105.85
LOQ
gmL−1
5.538.069.3914.71
Sandell’s sensitivity gcm−20.0001030.0670.0001710.096
Apparent Molar
absorptivity
LMol−1cm−1
383.010.59229.59

Average of three different trials of determinations.
3.1.1. Effect of pH

With increasing pH greater than 3, there is a decrease in extraction yield, probably because of precipitation of bismuth as hydroxo-species. The absorbance at remains constant in the pH range of 2.0–2.8. As the shape of the absorption maximum does not vary with pH, it is assumed that in this pH range only one type of ion pair is formed. The use of a suitable buffer solution was avoided because the presence of any foreign ion could interfere with the ion-pair formation; hence, 2% (v/v) of HNO3 was used to adjust the pH of the solution.

3.1.2. Effect of Bismuth Subnitrate Volume

Different volumes of bismuth subnitrate were added to a fixed concentration of each drug in the presence of other constituents of the procedure. It was found that 0.4 mL of  M bismuth subnitrate solution for CRV and 0.3 mL for PGZ-HCl were sufficient for the production of maximum and reproducible colour intensity (Figure 5).

3.1.3. Effect of Potassium Iodide Volume

Different volumes of potassium iodide were added to a fixed concentration of each drug in the presence of other constituents of the procedure. It was found that 0.5 mL of 0.5 M potassium iodide solution was suitable for PGZ-HCl, while 0.7 mL for CRV was sufficient for the production of maximum and reproducible color intensity (Figure 6).

3.1.4. Effect of Nitric Acid Volume

Different volumes of nitric acid were added to a fixed concentration of each drug in the presence of other constituents of the procedure. It was found that 0.7 mL of 2% (v/v) of nitric acid solution was suitable for PGZ-HCl, while 0.3 mL for CRV was sufficient for the production of maximum and reproducible color intensity (Figure 7).

3.1.5. Effect of Extracting Solvent

Many organic solvents were tried to extract the binary complexes formed. Preliminary experiments with number of organic solvents commonly used such as methylene chloride, ethyl acetate, ethylene chloride, benzene, and petroleum ether were constructed. It was found that methylene chloride was the appropriate solvent for the studied drugs.

3.1.6. Effect of Addition Order

The sequence of addition of the constituents of the complex was studied. The most suitable order was bismuth subnitrate, potassium iodide, drug, and then nitric acid to give most stability with higher sensitivity complex.

3.1.7. Effect of Reaction and Shaking Times

Maximum color intensity was attained immediately for CRV, while PGZ-HCl needed 5 minutes and complete extraction was attained by shaking for 1 minute for PGZ-HCl and 2 minutes for CRV. The intensities of the color produced were found to be stable for more than 1 hour (Figure 8).

3.1.8. Composition of the Ion Pair

The composition of the ion pairs formed was studied by Job’s method of nonequimolar solutions [45]. Bismuth subnitrate molecule contains five atoms of bismuth, so upon reaction with potassium iodide it gives five molecules of bismuth tetraiodide complex; after that the formed complex interacts with the studied drugs, which contain one site for the interaction, and gives the ion pair in the ratio (5 : 1), but this is difficult practically; nonequimolar solutions method is used for determination of the molar ratio of the formed ion pair. The obtained results showed that the composition of the ion pairs was (1 : 1) for both drugs (Figure 9).

Method Validation. The method was validated according to the International Conference of Harmonization (ICH) [46].

(1) Linearity and Concentration Ranges

For Procedure 1. Graph of the absorbance against concentrations proved to be linear in the range from 5 to 50 gmL−1 for PGZ-HCl and from 10 to 80 gmL−1 for CRV and determination coefficients () were 0.9999 for both drugs.

For Procedure 2. Graph of the absorbance against concentrations proved to be linear in the range from 15 to 65 gmL−1 for PGZ-HCl and from 16 to 72 gmL−1 for CRV and determination coefficients () were 0.9999 for both drugs.

(2) Limits of Detection and Limits of Quantitation

For Procedure 1. Limit of detection (LOD) was found to be 1.82 and 3.10 gmL−1 for PGZ-HCl and CRV, respectively. Limit of quantitation (LOQ) was found to be 5.53 gmL−1 and 9.93 gmL−1 for PGZ-HCl and CRV, respectively.

For Procedure 2. Limit of detection (LOD) was found to be 2.66 and 5.58 gmL−1 for PGZ-HCl and CRV, respectively. Limit of quantitation (LOQ) was found to be 8.06 gmL−1 and 14.71 gmL−1 for PGZ-HCl and CRV, respectively. Results are given in Table 2.

(3) Specificity of the Method. Results of the analysis were compared statistically to a reported method for PGZ-HCl and CRV applying the Student’s -test and the variance ratio test (-test). The results gave lower values than the theoretical ones indicating no significant difference between the performance of the proposed method and the reported methods (Table 3).


ParametersProcedure 1Procedure 2Procedure 1Procedure 2
Diabetin tabletsReference method [12]Diabetin tabletsReference method [12]Carvid tabletsReference method [13]Carvid tabletsReference method [13]

48585858
Mean recovery100.77100.23100.74100.23100.88100.0299.35100.02
Variance1.120.850.660.850.800.640.290.64
±SD1.060.920.810.920.890.800.530.80
±RSD1.110.920.800.920.880.800.530.80
±SE0.530.330.360.330.400.280.240.28
Student’s -test0.914 (2.23)a1.01
(2.20)a
1.81
(2.20)a
1.64
(2.20)a
-test1.32
(4.35)b
1.29
(4.12)b
1.25
(4.12)b
2.21
(4.12)b

a and b are the theoretical student -values and -ratios at .

(4) Repeatability and Precision of the Method. Table 4 shows that there are high intra- and interday precision. Intraday precision was assessed by injection of the standard solution of the drug at three concentration levels six times during a day. The same was done for interday precision test except that the experiment was done and the drugs were analyzed every day for six days.


Drug Taken conc
( g mL−1)
InterdayIntraday
Recovery
(%)a
Precision
(RSD%)a
Accuracy
(Er%)
Recovery
(%)a
Precision
(RSD%)a
Accuracy
(Er%)

PGZ-HCl1099.650.76−0.35100.931.190.93
15100.840.920.84100.571.030.57
40100.190.530.19100.220.890.22

CRV1599.571.16−0.4399.17 0.78−0.83
2499.980.78−0.0299.811.21−0.19
5099.060.95−0.94100.851.45 0.85

RSD%: percentage relative standard deviation.
Er%: percentage relative error.
aMean of five trials of determination.
3.2. Reaction with Organic Dyes (Method B)
3.2.1. Fast Green FCF Method

Absorption spectra of the reagents with PGZ-HCl and CRV were studied over range of 200–800 nm.

Fast green FCF reacts with PGZ-HCl and CRV to yield a blue colored complex exhibiting maximum absorption at 631 nm (Figures 10 and 11), and the ion pair formed can be extracted with methylene chloride. Different variables affecting the reaction were studied.

(1) Effect of pH on the Ion-Pair Formations. In order to establish the optimum pH value for each ion pair formed, various acids, for example, acetic, hydrochloric, and sulphuric acids of different molarities, were studied. The highest absorbance values were obtained using 0.1 M hydrochloric acid and 0.01 M acetic acid for PGZ-HCl and CRV, respectively. The optimum volume used for CRV was 0.4 mL of 0.01 M acetic acid to give the highest absorbance values, while 0.1 M hydrochloric acid was used as solvent for PGZ-HCl and for acidification of the medium (Figure 12).

(2) Effect of Reagent Conc. and Volume as well as Additions Order. The effect of reagent concentration was also studied. Highest constant absorbance was obtained on using 1 mL of fast green FCF (0.01% w/v) for both drugs PGZ-HCl and CRV (Figure 13). Moreover, the sequence of addition of the constituents of the complex was also studied. Addition of the drug followed by the dye and then the acid was recommended to obtain stable, high color intensity.

(3) Choice of Organic Solvent. A solvent is needed to extract the formed ion-pair to increase the selectivity of the assay. Preliminary experiment with a number of organic solvents commonly used (benzene, ethylacetate, methylene chloride, and ethylene chloride) for the ion-pair extraction was studied. Methylene chloride was the appropriate solvent because of its higher sensitivity and lower extraction ability of the reagents.

(4) Effect of Reaction Time and Number of Extraction Times. Reaction time required for complete color development of ion-pair complexes formed between the studied drugs and fast green FCF was studied. Maximum color intensity was attained immediately for both drugs to reach its maximum intensity. Complete extraction was attained by double extraction with ( mL) methylene chloride and then complete to 10 mL with the same solvent. The intensities of the color produced were found to be stable for about 1 hr for both drugs (Figure 14).

(5) Composition of the Ion-Pair Complexes. The composition of the ion pair was studied by Job’s method of continuous variation [44]. The obtained results showed that the composition of ion pair complexes was (1 : 1) (drug : reagent) for PGZ-HCl and (2 : 3) (drug : reagent) for CRV (Figure 15).

3.2.2. Orange G Method

Absorption spectra of the reagents with PGZ-HCl and CRV were studied over range of 200–800 nm. Orange G reacts with PGZ-HCl and CRV to yield an orange colored chromophore exhibiting maximum absorption at 498 nm (Figures 16 and 17), and the ion pair formed can be extracted with methylene chloride.

Different Variables Affecting the Reaction Were Studied

(1) Effect of pH on the Ion-Pair Formation. In order to establish the optimum pH value for each ion pair formed, various acids like hydrochloric, sulphuric, and acetic acids of different molarities were studied. The highest absorbance values were obtained using 0.5 M sulphuric acid and 2 M acetic acid for PGZ-HCl and CRV, respectively.

The optimum volume used for CRV was 0.2 mL of 2 M acetic acid to give the highest absorbance values while 0.5 M sulphuric acid was used as solvent for PGZ-HCl and for acidification of the medium (Figure 18).

(2) Choice of Organic Solvents. The results using different extracting solvents (benzene, ethylacetate, methylene chloride and ethylene chloride) indicated that methylene chloride is the most appropriate solvent for extraction and that can be attributed to its high extraction efficiency.

(3) Effect of Reagent Conc. and Volume as well as Additions Order. The effect of reagent concentration was also studied. Highest constant absorbance was obtained on using 0.5 mL of (0.4% w/v) and (0.2% w/v) orange G for PGZ-HCl and CRV, respectively (Figure 19). Moreover, the sequence of addition of the constituents of the complex was also studied. Addition of the drug followed by the dye and then the acid was recommended to obtain stable, high color intensity.

(4) Effect of Reaction Time and Number of Extraction Times. Reaction time required for complete color development of ion-pair complexes formed between the studied drugs and orange G was studied. Maximum color intensity was attained immediately for both drugs. Complete extraction was attained by double extraction with ( mL) methylene chloride and then complete to 10 mL with the same solvent. The intensities of the color produced were found to be stable for about 1 hr for both drugs (Figure 20).

(5) Composition of the Ion-Pair Complex. The composition of the ion-pair was studied by Job’s method of continuous variation [44]. The obtained results showed that the composition of ion-pair complex was (3 : 2) (drug : reagent) for PGZ-HCl and (1 : 1) (drug : reagent) for CRV (Figure 21).

Method Validation. The method was validated according to the International Conference of Harmonization (ICH) [46].

(1) Linearity and Concentration Ranges

Fast Green FCF Method. Graph of the absorbance against concentrations proved to be linear in the range from 0.5 to 4 gmL−1 for PGZ-HCl and from 0.5 to 3 gmL−1 for CRV and determination coefficients () were 0.9999 for both drugs (Table 5).


Parameters
PGZ-HClCRV
Fast green FCFOrange GFast green FCFOrange G

Conc. of reagent, w/v0.01% 0.4% 0.01% 0.2%
Vol. of reagent, mL1 0.5 1 0.5
, nm631498631498
Beer's law limits gmL−10.5–410–700.5–35–45
Regression equation*
 Intercept0.1116−0.0413−0.00550.0168
 Slope0.19450.01430.32010.0206
 Correlation Coefficient0.99990.99990.99990.9999
 Molar Ratio2 : 31 : 11 : 11 : 1
, where is the concentration of drug in gmL−1, is the absorbance,
is the intercept, and is the slope.

Orange G Method. Graph of the absorbance against concentrations proved to be linear in the range from 10 to 70 gmL−1 for PGZ-HCl and from 5 to 45 gmL−1 for CRV and determination coefficients () were 0.9999 for both drugs (Table 5).

(2) Limits of Detection and Limits of Quantitation

Fast Green FCF Method. Limit of detection (LOD) was found to be 0.13 and 0.078 gmL−1 for PGZ-HCl and CRV, respectively. Limit of quantitation (LOQ) was found to be 0.39 gmL−1 and 0.24 gmL−1 for PGZ-HCl and CRV, respectively.

Orange G Method. Limit of detection (LOD) was found to be 0.23 and 0.16 gmL−1 for PGZ-HCl and CRV, respectively. Limit of quantitation (LOQ) was found to be 0.7 gmL−1 and 0.49 gmL−1 for PGZ-HCl and CRV, respectively. Results are given in Table 6.


ParametersPGZ-HCl*CRV*
Fast green FCF methodOrange G methodFast green FCF methodOrange G method
Taken
gmL−1
Found
gmL−1
Recovery
%
Taken
gmL−1
Found
gmL−1
Recovery
%
Taken
gmL−1
Found
gmL−1
Recovery
%
Taken
gmL−1
Found
gmL−1
Recovery
%

0.50.51101.181010.02100.210.50.5099.6655.01100.19
10.9999.432020.02100.1011.0099.501010.01100.10
1.51.51100.573029.8199.371.51.50100.072019.8699.32
21.9899.074039.9599.8822.01100.362525.25101.01
2.52.51100.245050.44100.882.52.51100.413030.11100.36
33.0099.986060.23100.3832.9999.604040.01100.02
44.00100.057069.7499.634545.06100.13
Mean100.08100.0799.93100.16
±SD0.700.500.400.50
±RSD0.700.500.400.50
±SE0.260.190.160.19
Variance0.490.250.160.25
Slope0.19450.01430.32010.0206
LOD
gmL−1
0.130.230.0780.16
LOQ
gmL−1
0.390.70.240.49
Sandell’s
sensitivity
gcm−2
0.00360.0780.00320.046
Apparent Molar
absorptivity
LMol−1cm−1

Average of three different trials of determination.

(3) Specificity of the Method. Results of the analysis were compared statistically to a reported method for PGZ-HCl and CRV applying the Student’s -test and the variance ratio test (-test). The results gave lower values than the theoretical ones indicating no significant difference between the performance of the proposed method and the reported methods (Table 7).


ParametersDiabetin tabletsCarvid tablets
Fast green FCFOrange GReference method [12]Fast green FCFOrange GReference method [13]

458558
Mean
recovery
100.21100.41100.23100.18100.26100.02
Variance0.510.500.850.380.280.64
±SD0.720.710.920.620.530.80
±RSD0.720.710.920.620.530.80
±SE0.360.320.330.280.240.28
Student’s -test0.038
(2.23)a
0.41
(2.20)a
1.33
(2.20)a
0.59
(2.20)a
-test1.67
(4.35)b
1.70
(4.12)b
1.67
(4.12)b
2.27
(4.12)b

a and b are the theoretical student -values and -ratios at .

(4) Repeatability and Precision of the Method. Table 8 shows that there are high intra- and interday precision. Intraday precision was assessed by injection of the standard solution of the drug at three concentration levels six times during a day. The same was done for interday precision test except that the experiment was done and the drugs were analyzed every day for six days.


Drug Method Taken
conc.
( gmL−1)
InterdayIntraday
Recovery (%)aPrecision (RSD%)aAccuracy
(Er%)
Recovery (%)aPrecision
(RSD%)a
Accuracy
(Er%)

PGZ-HClFast green198.941.80−1.0699.241.03−0.76
299.551.09−0.4599.970.95−0.03
3100.130.78 0.1398.651.17−1.35
Orange G1099.411.31−0.5998.711.19−1.29
30101.450.981.4599.891.17−0.11
6099.081.13−0.92101.650.961.65

CRVFast green198.881.21−1.1298.561.23−1.44
2101.760.861.7699.871.38−0.13
399.681.49−0.3298.781.17−1.22
Orange G10100.431.310.43100.571.140.57
2598.130.87−1.87101.671.261.67
4099.871.34−0.13101.990.871.99

RSD%: percentage relative standard deviation.
Er%: percentage relative error.
aMean of five trials of determination.

4. Conclusions

The two proposed methods for determination of PGZ and CRV are based on the formation of ion-pair associates between the drugs and the inorganic complex, bismuth(III) tetraiodide (Method A), and between the drugs and the organic acidic dyes, fast green and orange G (Method B). Both methods were found to be sensitive, accurate, and precise. When the results obtained by the proposed methods were compared with those of reference methods, there was no significant difference. The proposed methods were applied for determination of the analytes in drug dosage form with good accuracy and without interference.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. S. C. Sweetman, Martindale, the Complete Drug Reference, 36th edition, 2009.
  2. M. Chennaiah, T. Veeraiah, T. C. Singh, and G. Venkateshwarlu, “Extractive spectrophotometric methods for determination of PGZ using acidic triphenylmethane dyes,” Asian Journal of Research in Chemistry, vol. 4, no. 6, pp. 971–975, 2011. View at: Google Scholar
  3. Z. H. Qin, G. M. Shen, Y. S. Liu, and H. S. Luo, “Spectrophotometric method for determination of PGZ with eosin Y,” Qinzonghui Fenxi Shiyanshi, vol. 27, no. 10, pp. 15–18, 2008. View at: Google Scholar
  4. R. S. Mehta, D. M. Patel, K. K. Bhatt, and M. B. Shankar, “UV and visible spectrophotometric analysis of pioglitazone hydrochloride in bulk and tablets,” Indian Journal of Pharmaceutical Sciences, vol. 67, no. 4, pp. 487–489, 2005. View at: Google Scholar
  5. K. Sujana, K. Abbulu, O. Bala Souri, B. Archana, M. Sindu, and G. Swathi Rani, “Difference spectrophotometric methods for pioglitazone hydrochloride and metform in hydrochloride,” Journal of Pharmaceutical Sciences and Research, vol. 3, no. 4, pp. 1122–1126, 2011. View at: Google Scholar
  6. S. Sharma and M. C. Sharma, “Determination of atorvastatin calcium and pioglitazone HCl in pharmaceutical formulations form by using atomic absorption spectrometry,” Optoelectronics and Advanced Materials, Rapid Communications, vol. 4, no. 8, pp. 1196–1199, 2010. View at: Google Scholar
  7. N. A. Al-Arfaj, E. A. Al-Abdulkareem, and F. A. Aly, “Flow-injection chemiluminometric determination of pioglitazone HCl by its sensitizing effect on the cerium-sulfite reaction,” Analytical Sciences, vol. 25, no. 3, pp. 401–406, 2009. View at: Publisher Site | Google Scholar
  8. N. A. Al-Arfaj, E. A. Al-Abdulkareem, and F. A. Aly, “A validated adsorptive stripping voltammetric determination of antidiabetic agent pioglitazone HCl in tablets and biological fluids,” International Journal of Biomedical Science, vol. 4, no. 4, pp. 310–318, 2008. View at: Google Scholar
  9. A. A. Abdelmonem, G. H. Ragab, H. Hashem, and E. A. Bahgat, “High performance liquid chromatographic and spectrophotometric determinations of PGZ-HCl either alone or in combination with Metformin-HCl,” Journal of Liquid Chromatography & Related Technologies, vol. 35, pp. 2706–2723, 2012. View at: Google Scholar
  10. A. Shirkhedkar and S. Surana, “Application of a stability-indicating densitometric RP-TLC method for analysis of pioglitazone hydrochloride in the bulk material and in pharmaceutical formulations,” Journal of Planar Chromatography: Modern TLC, vol. 22, no. 3, pp. 191–196, 2009. View at: Publisher Site | Google Scholar
  11. B. Siddartha and B. Sudheer, “Analytical method development and method validation for the estimation of PGZ in tablet dosage form by RP-HPLC,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 3, pp. 770–774, 2013. View at: Google Scholar
  12. P. K. Basniwal, P. K. Srivastava, and D. Jain, “Spectrophotometric estimation of PGZ in tablet dosage form,” Asian Journal of Pharmaceutical, vol. 2, pp. 225–227, 2008. View at: Google Scholar
  13. N. Verma, A. K. Ghosh, and P. Chattopadhyay, “Simultaneous spectrophotometric determination of CRV in its dosage form,” International Journal of Pharma Sciences and Research, vol. 1, no. 12, pp. 188–190, 2010. View at: Google Scholar
  14. The British Pharmacopoeia, Volumes II and III, Her Majesty’s Stationery Office, London, UK, 2009.
  15. S. G. Cardoso, C. V. S. Ieggli, and S. C. G. Pomblum, “Spectrophotometric determination of carvedilol in pharmaceutical formulations through charge-transfer and ion-pair complexation reactions,” Pharmazie, vol. 62, no. 1, pp. 34–37, 2007. View at: Publisher Site | Google Scholar
  16. C. Theivarasu, S. Ghosh, and T. Indumathi, “UV spectrophotometric determination of carvedilol in pharmaceutical formulations,” Asian Journal of Pharmaceutical and Clinical Research, vol. 3, no. 4, pp. 64–68, 2010. View at: Google Scholar
  17. Y. N. Rani, B. V. Ravikumar, and S. Mohanty, “Development and validation of new analytical methods for the estimation of carvedilol in bulk and pharmaceutical dosage forms,” Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 2, pp. 138–140, 2013. View at: Google Scholar
  18. S. D. Manohar, D. A. Sridhar, and S. C. Mallikarjuna, “Development of UV spectrophotometric method for estimation of carvedilol in bulk and pharmaceutical formulations,” Asian Journal of Research in Chemistry, vol. 6, no. 10, pp. 956–959, 2013. View at: Google Scholar
  19. I. Leonenko, D. Aleksandrova, and A. Yegorova, “Determination of carvedilol by its quenching effect on the luminescence of terbium complex in dosage form,” Acta Poloniae Pharmaceutica: Drug Research, vol. 68, no. 3, pp. 325–330, 2011. View at: Google Scholar
  20. A. Önal, “Spectrophotometric and spectrofluorimetric determination of some drugs containing secondary amino group in bulk drug and dosage forms via derivatization with 7-chloro-4-nitrobenzofurazon,” Química Nova, vol. 34, no. 4, pp. 677–682, 2011. View at: Publisher Site | Google Scholar
  21. C. V. S. Ieggli, S. G. Cardoso, and L. P. Belle, “Validation of UV spectrophotometric and nonaqueous titration methods for the determination of carvedilol in pharmaceutical formulations,” Journal of AOAC International, vol. 88, no. 5, pp. 1299–1303, 2005. View at: Google Scholar
  22. R. S. Haggag, R. A. Shaalan, and T. S. Belal, “Validated HPLC determination of the two fixed dose combinations (chlordiazepoxide hydrochloride and mebeverine hydrochloride; carvedilol and hydrochlorothiazide) in their tablets,” Journal of AOAC International, vol. 93, no. 4, pp. 1192–1200, 2010. View at: Google Scholar
  23. P. Sripalakit, S. Kaewnok, and S. Tubtonglang, “Development of carvedilol assay in tablet dosage form using HPLC with fluorescence detection,” Maejo International Journal of Science and Technology, vol. 4, no. 1, pp. 8–19, 2010. View at: Google Scholar
  24. J. Stojanovi, S. Vladimirov, V. Marinkovi, D. Velikovi, and P. Sibinovi, “Monitoring of the photochemical stability of CRV and its degradation products by the RP-HPLC method,” Journal of the Serbian Chemical Society, vol. 72, pp. 37–44, 2007. View at: Google Scholar
  25. M. Sylwia, A. Weronika, and B. Irena, “Simultaneous chiral separation and determination of CRV and 5′-hydroxyphenyl CRV enantiomers from human urine by high performance liquid chromatography coupled with fluorescent detection,” Central European Journal of Chemistry, vol. 11, no. 12, pp. 2076–2087, 2013. View at: Google Scholar
  26. T. S. Belal, F. A. El Yazbi, R. A. Shaalan, and S. M. Elonsy, “Validated stability-indicating HPLC-DAD determination of the antihypertensive binary mixture of carvedilol and hydrochlorothiazide in tablet dosage forms,” Chromatographia, vol. 76, no. 23-24, pp. 1707–1720, 2013. View at: Google Scholar
  27. D. P. Patel, P. Sharma, M. Sanyal, P. Singhal, and P. S. Shrivastav, “UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers,” Biomedical Chromatography, vol. 27, no. 8, pp. 974–986, 2013. View at: Google Scholar
  28. F. M. Abdel-Gawad, “Ion-pair formation of Bi(III)-iodide with some nitrogenous drugs and its application to pharmaceutical preparations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 16, no. 5, pp. 793–799, 1998. View at: Publisher Site | Google Scholar
  29. L. M. Abdellaziz and M. M. Hosny, “Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride,” Analytical Chemistry Insights, vol. 6, no. 1, pp. 67–78, 2011. View at: Publisher Site | Google Scholar
  30. A. M. El-Brashy, M. E.-S. Metwally, and F. A. El-Sepai, “Spectrophotometric and atomic absorption spectroscopic determination of some fluoroquinolone antibacterials by ion-pair complex formation with bismuth (III) tetraiodide,” Journal of the Chinese Chemical Society, vol. 52, no. 2, pp. 253–262, 2005. View at: Google Scholar
  31. M. Ayad, H. Abdellatef, M. Hosny, and N. Kabil, “Conductometric determination of certain pharmacological drugs using silver and bismuth,” International Research Journal of Pharmaceutical and Applied Sciences, vol. 3, no. 4, pp. 140–148, 2013. View at: Google Scholar
  32. C. S. P. Sastry, M. Aruna, M. Narayana Reddy, and D. G. Sankar, “Extractive spectrophotometric determination of some anthelmintics using fast green FCF or orange-II,” Indian Journal of Pharmaceutical Sciences, vol. 50, no. 2, pp. 140–142, 1988. View at: Google Scholar
  33. K. Sreedhar, C. S. P. Sastry, M. Narayana Reddy, and D. G. Sankar, “Spectrophotometric determination of mebeverine hydrochloride,” Mikrochimica Acta, vol. 126, no. 1-2, pp. 131–135, 1997. View at: Google Scholar
  34. M. Kishore, K. Surendrababu, C. S. R. G. Kalyani, and M. Janardhan, “Spectrophotometric determination of ceftiofur in pharmaceutical formulations by FGFCF, SFNO and MB,” Journal of Pharmaceutical Sciences and Research, vol. 2, no. 9, pp. 534–538, 2010. View at: Google Scholar
  35. L. Qiu-hua, “Kinetic spectrophotometric determination of trace ruthenium with fast green FCF,” Chinese Journal of Analysis Laboratory, vol. 26, pp. 60–62, 2007. View at: Google Scholar
  36. J. Zhiliang and Q. Qin Chen-zhen, “A new application of fast green in catalytic analysis-catalytic determination of ultratrace ruthenium with oscillopolarographic detection,” Electroanalysis, vol. 5, pp. 535–537, 1993. View at: Google Scholar
  37. S. Pillai and I. Singhvi, “Application of orange G dye for quantitation of citalopram hydrobromide, donepezil hydrochloride and rabeprazole sodium from tablet formulation,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 5, pp. 682–684, 2006. View at: Google Scholar
  38. A. Bhandage, A. Bhosale, A. Kasture, and V. P. Godse, “Extractive spectrophotometric determination of omeprazole in pharmaceutical preparations,” Tropical Journal of Pharmaceutical Research, vol. 8, no. 5, pp. 449–454, 2009. View at: Google Scholar
  39. B. Rajitha, S. Prashanthi, K. Ramsubha Reddy, and G. Tulja Rani, “Extractive spectrophotometric determination of tramadol hydrochloride in pure and pharmaceutical dosage forms,” International Journal of PharmTech Research, vol. 3, no. 1, pp. 114–117, 2011. View at: Google Scholar
  40. R. Tulja Rani, D. Gowri Sankar, P. Kadgapathi, R. Suthakaran, and B. Satyanarayana, “Visible spectrophotometric methods for the determination of drotaverine hydrochloride in bulk and in pharmaceutical formulations,” International Journal of PharmTech Research, vol. 2, no. 3, pp. 1787–1791, 2010. View at: Google Scholar
  41. H. M. Saleh, M. M. EL-Henawee, G. H. Ragab, and S. S. Abd EL-Hay, “Extractive spectrophotometric determination of some antihistaminic and skeletal muscle relaxant drugs through ion-pair formation with xylene cyanol and orange G,” Bulletin of Faculty of Pharmacy Cairo University, vol. 45, no. 3, pp. 373–390, 2007. View at: Google Scholar
  42. G. Jie, Y. Ming-Hui, Y. Zhi-Yi, L. Zu-Bi, and C. Qiu-E, “Kinetic spectrophotometric determination of trace ruthenium with orange G,” Chinese Journal of Analysis Laboratory, vol. 2, pp. 38–40, 2005. View at: Google Scholar
  43. S. Motomizu, M. Oshima, and Y. Hosoi, “Spectrophotometric determination of cationic and anionic surfactants with anionic dyes in the presence of nonionic surfactants, part I: a general aspect,” Mikrochimica Acta, vol. 106, no. 1-2, pp. 57–66, 1992. View at: Publisher Site | Google Scholar
  44. J. Mendham, R. C. Denney, J. D. Barnes, and M. Thomas, Vogel’s Textbook of Quantitative Chemical Analysis, Pearson Education, Essex, UK, 2000.
  45. W. C. Vosburg and G. R. Cooper, “Job method of non equimolar solution,” Journal of the American Chemical Society, vol. 63, pp. 437–442, 1941. View at: Google Scholar
  46. “Guidance for Industry: Q2B of Analytical Procedures, Methodololgy: International Conference of Harmonization (ICH),” 1996. View at: Google Scholar

Copyright © 2014 Afaf A. Abdelmonem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1705
Downloads558
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.